Previous Close | 16.45 |
Open | 16.21 |
Bid | 16.28 x 100 |
Ask | 16.35 x 400 |
Day's Range | 16.00 - 16.41 |
52 Week Range | 11.81 - 24.64 |
Volume | |
Avg. Volume | 532,796 |
Market Cap | 2.635B |
Beta (5Y Monthly) | 1.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Certara Inc (NASDAQ:CERT), a global leader in biosimulation, provides software, consulting, and technology-enabled services to support drug discovery, development, and regulatory science.
Key Insights The projected fair value for Certara is US$29.68 based on 2 Stage Free Cash Flow to Equity Current share...
Puma Biotechnology (PBYI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.